These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3114582)

  • 1. Antigastrolesive, gastric antisecretory, diarrheagenic and mucus-stimulating effects in rats following topically applied rioprostil, a synthetic prostaglandin E1 analog.
    Katz LB; Genna T; Scott CK; Rosenthale ME; Shriver DA
    Life Sci; 1987 Sep; 41(13):1591-8. PubMed ID: 3114582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric antisecretory and antigastrolesive pharmacology of rioprostil.
    Shriver DA; Katz LB; Rosenthale ME
    Scand J Gastroenterol Suppl; 1989; 164():10-20. PubMed ID: 2510252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
    Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
    J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
    Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
    Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antigastrolesive activity of rioprostil, a 16-methyl prostaglandin-E1 analogue in healthy volunteers.
    Cohen A; Tolman KG; Lewis GP; Brown S; van Horn A; McCormack GH; Simon DM
    Scand J Gastroenterol Suppl; 1989; 164():81-90; discussion 90-1. PubMed ID: 2510286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow release delivery of rioprostil by an osmotic pump inhibits the formation of acute aspirin-induced gastric lesions in dogs and accelerates the healing of chronic lesions without incidence of side effects.
    Katz LB; Shriver DA
    Toxicol Appl Pharmacol; 1989 Oct; 101(1):36-46. PubMed ID: 2508266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and physiological effects of a cytoprotective prostaglandin analog (rioprostil) on the rat gastric mucosa.
    Morris GP; Keenan CM; Shriver DA
    Clin Invest Med; 1987 May; 10(3):121-31. PubMed ID: 3113797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rioprostil prevents aspirin-induced fecal blood loss in dogs. Correlation of Hemoquant (Hb) with endoscopic findings.
    Katz LB; Fernandez JA; Schwartz S; Shriver DA
    Digestion; 1989; 42(4):217-23. PubMed ID: 2509266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisecretory and antigastrin effects of rioprostil in gastric fistula dogs.
    Katz LB; Genna T; Greeley GH; Shriver DA
    Dig Dis Sci; 1987 Nov; 32(11):1268-74. PubMed ID: 3117511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric effects of a prostaglandin E1-derivate (rioprostil) on acid, alkaline, and mucus secretion.
    Guslandi M; Passaretti S; Tittobello A; Fasani R
    Clin Ther; 1986; 8(6):619-23. PubMed ID: 3098425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rioprostil prevents gastric bleeding induced by nonsteroidal antiinflammatory drugs in dogs and arthritic rats.
    Katz LB; Capetola RJ; Argentieri DC; Moore LE; Genna T; Porter MC; Jasty V; Hartnagel RE; Abrutyn D; Shriver DA
    J Rheumatol; 1986 Oct; 13(5):887-94. PubMed ID: 3102726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiulcer effect of rioprostil, a prostaglandin E1 analog, in combination with antacid.
    Katz LB; Genna T; Shriver DA
    Life Sci; 1986 Sep; 39(11):1013-9. PubMed ID: 3091974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered susceptibility of arthritic rats to the gastric lesion-inducing effects of aspirin or ethanol and the antilesion effect of rioprostil.
    Katz LB; Genna T; Fuller BL; Tolman EL; Shriver DA
    Agents Actions; 1987 Oct; 22(1-2):134-43. PubMed ID: 3120518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
    Demol P; Singer MV; Dammann HG; Richardson CT; Weihrauch TR
    Scand J Gastroenterol Suppl; 1989; 164():74-9; discussion 79-80. PubMed ID: 2510285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of rioprostil on gastric emptying and intragastric acidity.
    Penston JG; Johnston DA; Wormsley KG
    Hepatogastroenterology; 1986 Jun; 33(3):120-2. PubMed ID: 3091468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rioprostil and the gastric mucus-bicarbonate barrier.
    Guslandi M; Fasani R; Tittobello A
    Scand J Gastroenterol Suppl; 1989; 164():92-5; discussion 95-6. PubMed ID: 2510287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of chronic rioprostil treatment on gastric endocrine function.
    Koop H; Schwarting H; Eckel U; Wagenknecht J; Hallfeldt U; Arnold R
    Scand J Gastroenterol Suppl; 1989; 164():104-10; discussion 110-1. PubMed ID: 2573147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the prostaglandin E1 analogue Rioprostil on the human gastric mucosa.
    Svendsen LB; Stener Jørgensen F; Hart Hansen O; Johansen A; Horn T; Larsen JK
    Digestion; 1987; 37(1):29-34. PubMed ID: 3111919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rioprostil on the gastric acid and bicarbonate secretion in patients with gastric ulcer.
    Krastev Z; Deredjian S; Matincheva R; Spasova Z; Karakasheva V
    Scand J Gastroenterol Suppl; 1989; 164():141-5. PubMed ID: 2510258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.